Dr Waiter stated that it was accepted that in order to meet the anticipated demand for principal plasma fractions, a new plant in addition to that already available in the UK must be acquired.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Self-Sufficiency
Key Person(s)
Dr Sheila Waiter